The DOI matches its Crossref record.
Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease
Abstract
OBJECTIVE: The purpose of this study was to determine the cardiovascular effects of fluoxetine in depressed patients with cardiac disease. METHOD: Twenty-seven depressed patients (26% of whom were female and whose average age was 73 years) who had congestive heart failure, conduction disease, and/or ventricular arrhythmia were studied in an open medication trial of fluoxetine, up to 60 mg/day, for 7 weeks. The main outcome measures were heart rate and rhythm measured by 24-hour ECG recordings, ejection fraction determined by radionuclide angiography, cardiac conduction intervals, and blood pressure. Baseline values were compared with those at weeks 2 and 7 of fluoxetine treatment. In 60 comparable patients, values of these same cardiovascular measures at baseline and after 3 weeks of treatment with a tricyclic antidepressant, nortriptyline, were also examined. RESULTS: Fluoxetine induced a statistically significant 6% decrease in heart rate, a 2% increase in supine systolic pressure, and a 7% increase in ejection fraction. There was no effect on cardiac conduction, ventricular arrhythmia, or orthostatic blood pressure. Overall, 4% of the fluoxetine patients had an adverse cardiovascular effect. In contrast, nortriptyline treatment caused a significant increase in heart rate and orthostatic hypotension, and 20% of the nortriptyline-treated patients had an adverse cardiovascular effect. CONCLUSIONS: In depressed patients with heart disease, fluoxetine treatment was not associated with the cardiovascular effects documented for the tricyclic antidepressants or with significant adverse cardiac events. However, limited conclusions about fluoxetine's cardiovascular effects and safety can be drawn from this study of only 27 patients monitored for 7 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.580 · Cited by 1,532
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Self-citationPage, R. L., O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C. M., Spencer, A. P., Trupp, R. J., & Lindenfeld, J. (2016) · Circulation · doi:10.1161/cir.0000000000000426 · Cited by 471
Comparison of Paroxetine and Nortriptyline in Depressed Patients With Ischemic Heart Disease
Roose, S. P. (1998) · JAMA · doi:10.1001/jama.279.4.287 · Cited by 453
Self-citationGrippo, A. J., & Johnson, A. K. (2009) · Stress · doi:10.1080/10253890802046281 · Cited by 452
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Pacher, P., & Kecskemeti, V. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383872 · Cited by 390
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
Serebruany, V. L., Glassman, A. H., Malinin, A. I., Nemeroff, C. B., Musselman, D. L., van Zyl, L. T., Finkel, M. S., Krishnan, K. R. R., Gaffney, M., Harrison, W., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085163.21752.0a · Cited by 340
Self-citationSelective Serotonin Reuptake Inhibitors and Myocardial Infarction
Sauer, W. H., Berlin, J. A., & Kimmel, S. E. (2001) · Circulation · doi:10.1161/hc4101.097519 · Cited by 319
The Influence of Anxiety and Depression on Outcomes of Patients With Coronary Artery Disease
Januzzi, J. L., Stern, T. A., Pasternak, R. C., & DeSanctis, R. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.1913 · Cited by 315
Relationship between major depression and heart rate variability.
Agelink, M. W., Boz, C., Ullrich, H., & Andrich, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00225-1 · Cited by 312
Antidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 287
Depression in patients with cardiac disease
Lespérance, F., & Frasure-Smith, N. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00102-6 · Cited by 284
Biological mechanisms in the relationship between depression and heart disease
Grippo, A. J., & Johnson, A. K. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00003-4 · Cited by 265
Strik, J. J. M. H., Honig, A., Lousberg, R., Lousberg, A. H. P., Cheriex, E. C., Tuynman-Qua, H. G., J. C. Kuijpers, P. M., Wellens, H. J. J., & Van Praag, H. M. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00007 · Cited by 254
Peretti, S., Judge, R., & Hindmarch, I. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10944.x · Cited by 236
A Comparison of the Risk of QT Prolongation Among SSRIs
Funk, K. A., & Bostwick, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013501994 · Cited by 174
Grippo, A. J., Beltz, T. G., Weiss, R. M., & Johnson, A. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.010 · Cited by 167
Evidence review: efficacy and effectiveness of antidepressant treatment in primary care
Simon, G. E. (2002) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00198-6 · Cited by 132
Mavrides, N., & Nemeroff, C. (2013) · Depression and Anxiety · doi:10.1002/da.22051 · Cited by 85
Dowlati, Y., Herrmann, N., Swardfager, W. L., Reim, E. K., & Lanctôt, K. L. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500205 · Cited by 79
Pharmacologic Treatment of Depression in Patients With Heart Disease
Roose, S. P., & Miyazaki, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163455.43226.bf · Cited by 76
Self-citationCardiovascular adverse effects of newer antidepressants
Mago, R., Tripathi, N., & Andrade, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908709 · Cited by 54
Treatment of depression in patients with congestive heart failure
Shapiro, P. A. (2009) · Heart Failure Reviews · doi:10.1007/s10741-007-9058-6 · Cited by 30
“In one of the first, 27 depressed patients admitted to an in-patient research unit received open label fluoxetine [18, 19].”
BackgroundAlves, T. C. T. F., Rays, J., Telles, R. M. S., Fráguas Júnior, R., Wajngarten, M., Romano, B. W., Watanabe, C., & Busatto, G. F. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.1.22 · Cited by 25
Metadata
- Authors
- Roose, S. P., Glassman, A. H., Attia, E., Woodring, S., Giardina, E.-G. V., & Bigger, J. T.
- Venue
- American Journal of Psychiatry
- Published
- 1998-05-01
- Volume
- 155
- Issue
- 5
- Pages
- 660-665
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2141625451
- Cited by
- 212
- References
- 0
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.